How should adult patients with neurofibromatosis 1 be managed?
- PMID: 29788480
- PMCID: PMC5961170
- DOI: 10.1093/neuonc/noy050
How should adult patients with neurofibromatosis 1 be managed?
Comment on
-
The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.Neuro Oncol. 2018 May 18;20(6):818-825. doi: 10.1093/neuonc/noy013. Neuro Oncol. 2018. PMID: 29409029 Free PMC article.
References
-
- Louis DN, Perry A, Reifenberger G, et al. . The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
-
- Dombi E, Solomon J, Gillespie AJ, et al. . NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology. 2007;68(9):643–647. - PubMed
-
- Meany H, Dombi E, Reynolds J, et al. . 18-Fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST). Pediatr Blood Cancer. 2013;60(1):59–64. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials